Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Simona Allocca
Observed names:
S Allocca,
S. Allocca
Observed institutions:
Institute of Neurological Sciences,
Nouscom (Italy),
University of Naples Federico II
ORCID:
0009-0009-4451-8497
Observed ORCID:
0009-0009-4451-8497
OpenAlex ID:
A5048923591
Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells
2018
·
Silvia Parisi
, Elena V. Polishchuk
, et al.
·
Scientific Reports
·
48
PDF
Differential phosphorylation-based regulation of αB-crystallin chaperone activity for multipass transmembrane proteins
2016
·
Michela Ciano
, Simona Allocca
, et al.
·
Biochemical and Biophysical Research Communications
·
33
PDF
Neuroocular Side Effects of Carbamazepine and Phenobarbital in Epileptic Patients as Measured by Saccadic Eye Movements Analysis
1989
·
G. Tedeschi
, G. Casucci
, et al.
·
Epilepsia
·
24
Age-dependent changes in visually guided saccadic eye movements.
1990
·
G Tedeschi
, A Di Costanzo
, et al.
·
PubMed
·
21
Computer analysis of saccadic eye movements: assessment of two different carbamazepine formulations
1989
·
G. Tedeschi
, G. Casucci
, et al.
·
European Journal of Clinical Pharmacology
·
17
An αB-Crystallin Peptide Rescues Compartmentalization and Trafficking Response to Cu Overload of ATP7B-H1069Q, the Most Frequent Cause of Wilson Disease in the Caucasian Population
2018
·
Simona Allocca
, Michela Ciano
, et al.
·
International Journal of Molecular Sciences
·
16
PDF
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024
·
Irene Garzia
, Linda Nocchi
, et al.
·
Cancer Immunology Research
·
13
PDF
VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens’ Prediction
2021
·
Guido Leoni
, Anna Morena D’Alise
, et al.
·
Vaccines
·
13
PDF
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer
2023
·
Anna Morena D’Alise
, Linda Nocchi
, et al.
·
Frontiers in Immunology
·
12
PDF
Saccadic eye movements analysis in the early diagnosis of myasthenia gravis
1991
·
G. Tedeschi
, A. Di Costanzo
, et al.
·
The Italian Journal of Neurological Sciences
·
11
Role of saccadic analysis in the diagnosis of multiple sclerosis in the era of magnetic resonance imaging.
1989
·
G Tedeschi
, S Allocca
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
9
PDF
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity
2023
·
Laura Seclì
, Luigia Infante
, et al.
·
Journal for ImmunoTherapy of Cancer
·
7
PDF
The contribution of saccadic eye movements analysis, visual and auditory evoked responses to the diagnosis of multiple sclerosis
1989
·
G. Tedeschi
, S. Allocca
, et al.
·
Clinical Neurology and Neurosurgery
·
6
A pharmacodynamic study of quazepam and triazolam
1991
·
G. Casucci
, A. di Costanzo
, et al.
·
Human Psychopharmacology Clinical and Experimental
·
4
Age-dependent changes in saccadic eye movements.
1987
·
Gioacchino Tedeschi
, Alfonso Di Costanzo
, et al.
·
4
Author Correction: Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells
2020
·
Silvia Parisi
, Elena V. Polishchuk
, et al.
·
Scientific Reports
·
3
PDF
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine
2024
·
Rosa Bartolomeo
, Fulvia Troise
, et al.
·
Vaccines
·
2
PDF
Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors
2024
·
Fulvia Troise
, Guido Leoni
, et al.
·
Molecular Therapy Oncology
·
2
Saccadic eye movements analysis: a new tool for the diagnosis of multiple sclerosis
1986
·
Gioacchino Tedeschi
, Simona Allocca
, et al.
·
1
Supplementary Figure 5 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2026
·
Irene Garzia
, Linda Nocchi
, et al.
Supplementary Figure 1 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2026
·
Irene Garzia
, Linda Nocchi
, et al.
Supplementary Figure 2 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2026
·
Irene Garzia
, Linda Nocchi
, et al.
Supplementary Figure 6 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2026
·
Irene Garzia
, Linda Nocchi
, et al.
Supplementary Figure 4 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2026
·
Irene Garzia
, Linda Nocchi
, et al.
Supplementary Figure 3 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2026
·
Irene Garzia
, Linda Nocchi
, et al.
Show more works
View as search
Works count:
51
Citation count:
246
H-index:
10
I10-index:
10
Year
Topic
Type